InspireMD, Inc. (NSPR) income statement
NSPRNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 10/3054% below fair value
$0.69+0.04 (+5.48%)
Close on Nov 18, 2026Market cap $31.87MP/E –Yield –
InspireMD, Inc. income statement
Ratios
Latest available, balances at Jun 30, 2026
Profitability, TTM
- Gross margin
- 18.1%
- Operating margin
- -494.0%
- Net margin
- -484.1%
- Return on equity, FY2025
- -106.9%
Financial strength
- Current ratio
- 3.80
- Debt to equity
- –
- Debt to assets
- –
- Cash to current liabilities
- 157.0%
Valuation
- P/E ratio
- –
- Price to sales
- 2.94
- Price to book
- 1.01
- Dividend yield
- –
See a number that looks wrong?